{"schema_version":"secwatch.filing_event.v1","accession":"0001214659-23-010804","form_type":"8-K","ticker":"ALZN","cik":"0001677077","company_name":"Alzamend Neuro, Inc.","filed_at":"2023-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.826013+00:00","generated_at":"2026-06-12T04:28:10.529399+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Alzamend Neuro receives Nasdaq delisting notice; hearing scheduled for Oct 12","bullets":["Nasdaq notified Alzamend on Aug 1, 2023 it failed to regain compliance with $1 bid price rule.","Company ineligible for second 180-day period due to not meeting $5M stockholders' equity initial listing requirement.","Delisting was scheduled for Aug 10, 2023, but stay granted pending appeal to Nasdaq Hearings Panel.","Hearing set for Oct 12, 2023; common stock continues trading under symbol ALZN during stay.","Company has submitted required appeal by Aug 8, 2023 deadline."],"urls":{"canonical":"https://secwatch.observer/filing/0001214659-23-010804","json":"https://secwatch.observer/filing/0001214659-23-010804.json","markdown":"https://secwatch.observer/filing/0001214659-23-010804.md","text":"https://secwatch.observer/filing/0001214659-23-010804.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1677077/000121465923010804/0001214659-23-010804-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1677077/000121465923010804/o872318k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T04:28:10.529399+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}